The capital of UCB has not been modified in 2020. On December 31, 2020, it amounted to €583 516 974 and was represented by 194 505 658 shares.
Since March 13, 2014, the share capital of UCB is represented by 194 505 658 shares, all fully paid up (“UCB shares”). UCB shares may be in registered or dematerialized form, at the request of the shareholder, in accordance with the BCCA.
Pursuant to the Belgian Law of December 14, 2005, bearer securities have been subject to a gradual abolishment, leading to their conversion into registered or dematerialized securities as from January 1, 2014, a mandatory sale of outstanding bearer shares by the Company in June 2015 and their complete abolishment at the end of 2015.
As of January 1, 2016, the rightful owners of unclaimed bearer shares have the right to claim the payment of the corresponding net proceeds of the mandatory sale from the Belgian Deposit and Consignment Fund (“Caisse des Dépôts et Consignations“/“Deposito- en Consignatiekas“) subject to evidence of their valid title to the shares and subject to a fine of 10% of the proceeds of the sale of the underlying bearer shares per each commenced year of arrears. More details are available on UCB’s website .
Registered UCB shares are recorded in the share register of UCB. All UCB shares are admitted for listing and trading on Euronext Brussels.
3.2.3 Treasury shares
In accordance with article 12 of the articles of association of UCB (the ‘Articles of Association ’), the Extraordinary General Meeting of April 30, 2020 decided to renew, for a period of 2 years starting on July 1, 2020 and expiring on June 30, 2022, the authorization granted to the Board of Directors to acquire, directly or indirectly, whether on or outside of the stock exchange, by way of purchase, exchange, contribution or any other way, up to 10% of the total number of the Company’s shares, as calculated on the date of each acquisition, for a price or an exchange value per share which will not be (i) higher than the highest price of the Company’s shares on Euronext Brussels on the day of the acquisition and (ii) lower than one (1) euro, without prejudice to article 8:5 of the royal decree of April 29, 2019 implementing the Belgian Code of Companies and Associations. As a result of such acquisition(s), the Company, together with its direct or indirect subsidiaries, as well as persons acting on their own behalf but for the account of the Company or its direct or indirect subsidiaries, may not hold more than 10% of the total number of shares issued by the Company at the moment of the acquisition concerned. This authorization extends to any acquisitions of the Company’s shares, directly or indirectly, by the Company’s direct subsidiaries in accordance with article 7:221 of the BCCA. The authorization granted by the Extraordinary General Meeting of the Company on April 26, 2018 remained valid until June 30, 2020.
In 2020, UCB SA acquired 5 301 306 UCB shares and disposed of 1 570 764 UCB shares. On December 31, 2020, UCB SA held a total of 5 480 222 UCB shares representing 2.82% of the total number of UCB shares, and no other UCB securities.
In 2020, UCB Fipar SA, an indirect subsidiary of UCB, acquired no UCB shares and disposed of 4 101 306 UCB shares (sold to UCB SA via 2 cross transactions). On December 31, 2020 UCB Fipar SA did not hold any UCB shares or other UCB securities.
The UCB shares were acquired by UCB SA in order to cover part of UCB’s obligations resulting from the employees’ stock option plans, stock award plans and performance share plans. Some of these shares were thereafter transferred to other UCB affiliates during 2020 for the sole purpose of delivering them to the employees of such other affiliates. Since these shares have all been delivered to eligible employees, none of such other affiliates is still holding UCB shares on December 31, 2020. For additional details, please refer to Note 27.2 Treasury shares.
3.2.4 Authorized capital
The Extraordinary General Meeting of April 30, 2020 decided to renew the authorization to the Board (and to amend the Articles of Association accordingly), for a period of 2 years, to increase the share capital, amongst other by way of the issuance of shares, convertible bonds or warrants, in one or more transactions, within the limits set by the BCCA.
with up to 5% of the share capital calculated at the time of the decision of the Board to make use of this authorization, in the event of a capital increase with cancellation or limitation of the preferential subscription rights of the shareholders (whether or not for the benefit of one or more specific persons who are not employees of the company or of its subsidiaries);
with up to 10% of the share capital calculated at the time of the decision of the Board to make use of this authorization, in the event of a capital increase without cancellation or limitation of the preferential subscription rights of the existing shareholders.
In any event, the total amount by which the Board may increase the share capital by a combination of the authorizations set forth in (i) and (ii) above, is limited to 10% of the share capital at the time of the decision of the Board to make use of this authorization.
The Board is moreover expressly authorized to make use of this mandate, within the limits as set out under (i) and (ii) above, for the following operations:
a capital increase or the issuance of convertible bonds or warrants with cancellation or limitation of the preferential subscription rights of the existing shareholders,
a capital increase or the issuance of convertible bonds or subscription rights with cancellation or limitation of the preferential subscription rights of the existing shareholders for the benefit of one or more specific persons who are not employees of the company or of its subsidiaries, and
a capital increase by incorporation of reserves.
Any such capital increase may take any and all forms, including, but not limited to, contributions in cash or in kind, with or without share premium, with issuance of shares below, above or at par value, the incorporation of reserves and/or share premiums and/or profits carried forward, to the maximum extent permitted by the Law.
Any decision of the Board to use this authorization requires a 75% majority within the Board.
The Board is empowered, with full power of substitution, to amend the Articles of Association to reflect the capital increases resulting from the exercise of its authorization.
The BCCA does not allow the use of this authorization as of the moment the Company has been notified by the Financial Services and Markets Authority (the ‘FSMA’) about a public takeover bid.